[1]
almajidi, Y.Q. et al. 2022. Preparation and Evaluation of Oroslippery Tablets Contain Irbesartan and Hydrochlorothiazide Combination for Dysphagia Patients. Iraqi Journal of Pharmaceutical Sciences. 31, 2 (Dec. 2022), 91–100. DOI:https://doi.org/10.31351/vol31iss2pp91-100.